Cargando…

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

Postprandial dyslipidaemia may be a plausible mechanism by which polycystic ovary syndrome (PCOS) increases cardiovascular risk. We sought to investigate whether the postprandial glucose and insulin and lipid and lipoprotein responses, including that of apolipoprotein B-48 (apoB-48) containing chylo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyaw Tun, Tommy, McGowan, Anne, Phelan, Niamh, Correia, Neuman, Boran, Gerard, O'Connor, Anna-Louise, Roche, Helen M., Gibney, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775795/
https://www.ncbi.nlm.nih.gov/pubmed/26989412
http://dx.doi.org/10.1155/2016/9545239
_version_ 1782419060041973760
author Kyaw Tun, Tommy
McGowan, Anne
Phelan, Niamh
Correia, Neuman
Boran, Gerard
O'Connor, Anna-Louise
Roche, Helen M.
Gibney, James
author_facet Kyaw Tun, Tommy
McGowan, Anne
Phelan, Niamh
Correia, Neuman
Boran, Gerard
O'Connor, Anna-Louise
Roche, Helen M.
Gibney, James
author_sort Kyaw Tun, Tommy
collection PubMed
description Postprandial dyslipidaemia may be a plausible mechanism by which polycystic ovary syndrome (PCOS) increases cardiovascular risk. We sought to investigate whether the postprandial glucose and insulin and lipid and lipoprotein responses, including that of apolipoprotein B-48 (apoB-48) containing chylomicrons, to a mixed meal are different in obese PCOS women when compared to obese control subjects and whether differences, if any, are related to obesity, insulin resistance (IR), hyperandrogenaemia, or PCOS status. 26 women with PCOS (age 30.4 ± 1.2 years (mean ± SEM), body mass index (BMI) 36.8 ± 1.5 kg/m(2)) and 26 non-PCOS subjects (age 34.1 ± 0.9 years, BMI 31.5 ± 1.0 kg/m(2)) were studied before and up to 8 hours following a standard mixed meal. AUC-triglyceride (AUC-TG) was higher and AUC-high-density lipoprotein (AUC-HDL) lower in PCOS women. These differences were not apparent when BMI was accounted for. Insulin sensitivity (S (I)), AUC-apoB-48, and AUC-apolipoprotein B (AUC-apoB) were found to be independent predictors of AUC-TG, accounting for 55% of the variance. Only AUC-insulin remained significantly elevated following adjustment for BMI. Obesity related IR explains postprandial hypertriglyceridaemia and hyperinsulinaemic responses. Management of obesity in premenopausal women with PCOS is likely to reduce their cardiovascular risk burden.
format Online
Article
Text
id pubmed-4775795
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-47757952016-03-17 Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome Kyaw Tun, Tommy McGowan, Anne Phelan, Niamh Correia, Neuman Boran, Gerard O'Connor, Anna-Louise Roche, Helen M. Gibney, James Int J Endocrinol Research Article Postprandial dyslipidaemia may be a plausible mechanism by which polycystic ovary syndrome (PCOS) increases cardiovascular risk. We sought to investigate whether the postprandial glucose and insulin and lipid and lipoprotein responses, including that of apolipoprotein B-48 (apoB-48) containing chylomicrons, to a mixed meal are different in obese PCOS women when compared to obese control subjects and whether differences, if any, are related to obesity, insulin resistance (IR), hyperandrogenaemia, or PCOS status. 26 women with PCOS (age 30.4 ± 1.2 years (mean ± SEM), body mass index (BMI) 36.8 ± 1.5 kg/m(2)) and 26 non-PCOS subjects (age 34.1 ± 0.9 years, BMI 31.5 ± 1.0 kg/m(2)) were studied before and up to 8 hours following a standard mixed meal. AUC-triglyceride (AUC-TG) was higher and AUC-high-density lipoprotein (AUC-HDL) lower in PCOS women. These differences were not apparent when BMI was accounted for. Insulin sensitivity (S (I)), AUC-apoB-48, and AUC-apolipoprotein B (AUC-apoB) were found to be independent predictors of AUC-TG, accounting for 55% of the variance. Only AUC-insulin remained significantly elevated following adjustment for BMI. Obesity related IR explains postprandial hypertriglyceridaemia and hyperinsulinaemic responses. Management of obesity in premenopausal women with PCOS is likely to reduce their cardiovascular risk burden. Hindawi Publishing Corporation 2016 2016-02-18 /pmc/articles/PMC4775795/ /pubmed/26989412 http://dx.doi.org/10.1155/2016/9545239 Text en Copyright © 2016 Tommy Kyaw Tun et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kyaw Tun, Tommy
McGowan, Anne
Phelan, Niamh
Correia, Neuman
Boran, Gerard
O'Connor, Anna-Louise
Roche, Helen M.
Gibney, James
Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
title Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
title_full Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
title_fullStr Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
title_full_unstemmed Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
title_short Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
title_sort obesity and insulin resistance are the main determinants of postprandial lipoprotein dysmetabolism in polycystic ovary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775795/
https://www.ncbi.nlm.nih.gov/pubmed/26989412
http://dx.doi.org/10.1155/2016/9545239
work_keys_str_mv AT kyawtuntommy obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT mcgowananne obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT phelanniamh obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT correianeuman obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT borangerard obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT oconnorannalouise obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT rochehelenm obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome
AT gibneyjames obesityandinsulinresistancearethemaindeterminantsofpostprandiallipoproteindysmetabolisminpolycysticovarysyndrome